Yon Ko

4.4k total citations · 1 hit paper
69 papers, 3.1k citations indexed

About

Yon Ko is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yon Ko has authored 69 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Yon Ko's work include Receptor Mechanisms and Signaling (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Glutathione Transferases and Polymorphisms (6 papers). Yon Ko is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Glutathione Transferases and Polymorphisms (6 papers). Yon Ko collaborates with scholars based in Germany, United States and United Kingdom. Yon Ko's co-authors include Agapios Sachinidis, H. Vetter, Thomas J. Neuhaus, Sebastian Stier, Claudia Seul, Elisabeth Grünewald, Ioanna Gouni‐Berthold, Laura M. Calvi, Tao Cheng and David Dombkowski and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Yon Ko

68 papers receiving 3.0k citations

Hit Papers

Osteopontin is a hematopoietic stem cell niche component ... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size
    2005 523 citations Sebastian Stier, Yon Ko et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yon Ko Germany 31 1.2k 656 591 493 389 69 3.1k
Masaru Harada Japan 31 1.1k 0.9× 627 1.0× 249 0.4× 149 0.3× 294 0.8× 198 4.0k
Hui Huang China 28 870 0.7× 316 0.5× 407 0.7× 188 0.4× 271 0.7× 187 2.7k
Soumeya Bekri France 29 1.2k 1.0× 198 0.3× 699 1.2× 473 1.0× 208 0.5× 124 3.4k
Antonio Macciò Italy 38 1.2k 1.0× 1.1k 1.7× 336 0.6× 182 0.4× 465 1.2× 145 4.4k
Franck Peiretti France 31 1.5k 1.2× 341 0.5× 363 0.6× 123 0.2× 587 1.5× 82 3.6k
Angéla Sutton France 37 1.5k 1.2× 591 0.9× 171 0.3× 120 0.2× 383 1.0× 93 4.3k
Lijian Shao China 27 1.7k 1.4× 476 0.7× 422 0.7× 286 0.6× 368 0.9× 64 3.6k
José J. Fuster Spain 31 1.6k 1.3× 266 0.4× 1.2k 2.0× 859 1.7× 442 1.1× 65 4.7k
Anjana Munshi India 31 1.1k 0.9× 415 0.6× 204 0.3× 144 0.3× 459 1.2× 157 2.9k
Gur P. Kaushal United States 36 1.6k 1.3× 425 0.6× 172 0.3× 140 0.3× 423 1.1× 56 3.6k

Countries citing papers authored by Yon Ko

Since Specialization
Citations

This map shows the geographic impact of Yon Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yon Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yon Ko more than expected).

Fields of papers citing papers by Yon Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yon Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yon Ko. The network helps show where Yon Ko may publish in the future.

Co-authorship network of co-authors of Yon Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Yon Ko. A scholar is included among the top collaborators of Yon Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yon Ko. Yon Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Michael, Ulrich Mey, Yon Ko, et al.. (2010). Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Supportive Care in Cancer. 19(7). 1009–1018. 108 indexed citations
2.
Pesch, Beate, Volker Harth, Sylvia Rabstein, et al.. (2009). Night work and breast cancer – results from the German GENICA study. Scandinavian Journal of Work Environment & Health. 36(2). 134–141. 104 indexed citations
3.
Ji, Yuan, Janet E. Olson, Jianping Zhang, et al.. (2008). Breast Cancer Risk Reduction and Membrane-Bound Catechol O -Methyltransferase Genetic Polymorphisms. Cancer Research. 68(14). 5997–6005. 36 indexed citations
4.
Haas, Susanne, Christiane Barbara Pierl, Volker Harth, et al.. (2006). Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. International Journal of Cancer. 119(8). 1785–1791. 56 indexed citations
5.
Stier, Sebastian, Thomas J. Neuhaus, Peter Albers, et al.. (2006). Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach. Archives of Toxicology. 80(10). 713–718. 3 indexed citations
6.
Stier, Sebastian, Yon Ko, Randolf Forkert, et al.. (2005). Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. The Journal of Experimental Medicine. 201(11). 1781–1791. 523 indexed citations breakdown →
7.
Rashid, Muhammad Usman, Anna Jakubowska, Christina Justenhoven, et al.. (2005). German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. European Journal of Cancer. 41(18). 2896–2903. 27 indexed citations
8.
Choi, Ji‐Yeob, Josef Abel, Thomas J. Neuhaus, et al.. (2003). Role of alcohol and genetic polymorphisms of CYP2E1 and ALDH2 in breast cancer development. Pharmacogenetics. 13(2). 67–72. 53 indexed citations
9.
10.
Gouni‐Berthold, Ioanna, Heiner K. Berthold, Claudia Seul, et al.. (2001). Effects of authentic and VLDL hydrolysis‐derived fatty acids on vascular smooth muscle cell growth. British Journal of Pharmacology. 132(8). 1725–1734. 12 indexed citations
11.
Seul, Claudia, H. Vetter, Agapios Sachinidis, et al.. (2001). Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(2). 215–221. 31 indexed citations
12.
Fischer, Hans‐Peter, et al.. (2000). Chronic liver disease in heterozygous α1-antitrypsin deficiency PiZ. Journal of Hepatology. 33(6). 883–892. 54 indexed citations
13.
Sachinidis, Agapios, Claudia Seul, Ioanna Gouni‐Berthold, et al.. (2000). Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle α‐actin content and abolishes the platelet‐derived growth factor‐BB‐stimulated DNA synthesis. British Journal of Pharmacology. 130(7). 1561–1570. 7 indexed citations
14.
Rothe, Marcus, Yon Ko, Peter Albers, & Nicolas Wernert. (2000). Eukaryotic Initiation Factor 3 p110 mRNA Is Overexpressed in Testicular Seminomas. American Journal Of Pathology. 157(5). 1597–1604. 52 indexed citations
15.
Sachinidis, Agapios, Claudia Seul, Yon Ko, Rainer Düsing, & H. Vetter. (1996). Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II‐induced vascular smooth muscle cell growth. British Journal of Pharmacology. 119(5). 787–796. 8 indexed citations
16.
Totzke, Gudrun, Agapios Sachinidis, H. Vetter, & Yon Ko. (1996). Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression. Molecular and Cellular Probes. 10(6). 427–433. 18 indexed citations
17.
Flesch, Markus, Yon Ko, Claudia Seul, et al.. (1995). Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells. European Journal of Pharmacology Molecular Pharmacology. 289(2). 399–402. 12 indexed citations
18.
19.
Sachinidis, Agapios, et al.. (1992). The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar???Kyoto rats. Journal of Hypertension. 10(10). 1159–1164. 21 indexed citations
20.
Sachinidis, Agapios, et al.. (1992). Angiotensin II induces formation of the early growth response gene‐1 protein in rat vascular smooth muscle cells. FEBS Letters. 313(2). 109–112. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaru Harada Breakdown of academic impact, for papers by Hui Huang Breakdown of academic impact, for papers by Soumeya Bekri Breakdown of academic impact, for papers by Antonio Macciò Breakdown of academic impact, for papers by Franck Peiretti Breakdown of academic impact, for papers by Angéla Sutton Breakdown of academic impact, for papers by Lijian Shao Breakdown of academic impact, for papers by José J. Fuster Breakdown of academic impact, for papers by Anjana Munshi Breakdown of academic impact, for papers by Gur P. Kaushal
Rankless by CCL
2026